Xencor Inc. Stock
Xencor Inc. Stock
The price for the Xencor Inc. stock decreased slightly today. Compared to yesterday there is a change of -€0.100 (-0.910%).
With 14 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
With a target price of 22 € there is potential for a 101.83% increase which would mean more than doubling the current price of 10.9 € for Xencor Inc..
Pros and Cons of Xencor Inc. in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Xencor Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Xencor Inc. | -0.910% | 0.000% | 3.774% | 21.547% | -13.386% | -56.000% | -69.904% |
| Ligand Pharmaceuticals | 1.010% | 4.211% | 11.864% | 107.330% | 19.277% | 182.857% | 63.704% |
| United Therapeutics | -1.160% | -3.219% | 3.308% | 88.659% | 13.293% | 134.886% | 176.629% |
| Ionis Pharmaceuticals Inc. | -1.860% | -2.798% | -0.509% | 139.159% | -7.975% | 91.195% | 77.117% |
Comments
Xencor (XNCR) had its price target raised by Barclays PLC from $26.00 to $27.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for XNCR provided by MarketBeat
Xencor (NASDAQ:XNCR) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating on the stock.
Show more
Ratings data for XNCR provided by MarketBeat
Xencor (NASDAQ:XNCR) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $26.00 price target on the stock.
Show more
Ratings data for XNCR provided by MarketBeat